Galecto Biotech

Galecto Biotech AB develops galectin modulators for the treatment of severe diseases, including fibrosis and cancer. The company builds on more than 10 years of research into galectins and galectin modulators, which combined with a strong patent estate gives Galecto Biotech a unique platform.

Contact name:

Hans Schambye

Address:

Ole Maaløes Vej 3, 2200 Copenhagen, Denmark

If you cannot find what you are looking for or if you have feedback to our website, please do not hesitate to contact dd@danskbiotek.dk or +45 5150 0560

Copyright 2012 Danskbiotek. All rights reserved.